D1 receptors play a major role in the dopamine modulation of mouse ileum contractility

Pharmacological Research

Volumn 61, Issue 5, 2010, Pages 371-378

  Zizzo, Maria Grazia ^a   Mulè, Flavia ^a   Mastropaolo, Mariangela ^a   Serio, Rosa ^a  

^a UNIVERSITY OF PALERMO   (Italy)

Author keywords

Contractile activity; D1 receptors; D2 receptors; Dopamine; Mouse ileum; Potassium channels

Indexed keywords

2,3,4,5 TETRAHYDRO 7,8 DIHYDROXY 1 PHENYL 1H 3 BENZAZEPINE; 8 CHLORO 2,3,4,5 TETRAHYDRO 3 METHYL 5 PHENYL 1H 3 BENZAZEPIN 7 OL HYDROGEN MALEATE; ADENOSINE RECEPTOR BLOCKING AGENT; ADENYLATE CYCLASE; ADENYLATE CYCLASE INHIBITOR; APAMIN; ATROPINE; DOMPERIDONE; DOPAMINE; DOPAMINE 1 RECEPTOR; NITRIC OXIDE SYNTHASE INHIBITOR; POTASSIUM CHANNEL; SULPIRIDE; TETRODOTOXIN;

ANIMAL TISSUE; ARTICLE; CONCENTRATION RESPONSE; CONTROLLED STUDY; ILEUM CONTRACTION; IN VITRO STUDY; INTESTINE CONTRACTION; MOUSE; MUSCLE ISOMETRIC CONTRACTION; NONHUMAN; PRIORITY JOURNAL; PROTEIN FUNCTION; RECEPTOR UPREGULATION;

ADENYLATE CYCLASE; ANIMALS; BENZAZEPINES; DOPAMINE; DOPAMINE ANTAGONISTS; DOSE-RESPONSE RELATIONSHIP, DRUG; ENTERIC NERVOUS SYSTEM; ILEUM; MICE; MUSCLE CONTRACTION; POTASSIUM CHANNELS; RECEPTORS, DOPAMINE D1; RECEPTORS, DOPAMINE D2;

EID: 77950629122     PISSN: 10436618     EISSN: 10961186     Source Type: Journal    
DOI: 10.1016/j.phrs.2010.01.015     Document Type: Article

References (36)

1. Scheibner J., Trendelenburg A.U., Hein L., Starke K., Blandizzi C. alpha(2)-Adrenoceptors in the enteric nervous system: a study in alpha(2A)-adrenoceptor-deficient mice. Br J Pharmacol 2002, 135:697-704.
2. Gershon M.D. Inhibition of gastrointestinal movement by sympathetic nerve stimulation: the site of action. J Physiol 1967, 189:317-327.
3. Anlauf M., Schafer M.K., Eiden L., Weihe E. Chemical coding of the human gastrointestinal nervous system: cholinergic, VIPergic, and catecholaminergic phenotypes. J Comp Neurol 2003, 459:90-111.
4. Li Z.S., Pham T.D., Tamir H., Chen J.J., Gershon M.D. Enteric dopaminergic neurons: definition, developmental lineage, and effects of extrinsic denervation. J Neurosci 2004, 24:1330-1339.
5. Dawirs R.R., Teuchert-Noodt G., Kampen W.U. Demonstration of dopamine-immunoreactive cells in the gastrointestinal tract of gerbils (Meriones unguiculatus). J Histochem Cytochem 1992, 40:1197-1201.
6. Eisenhofer G., Aneman A., Friberg P., Hooper D., Fåndriks L., Lonroth H., et al. Substantial production of dopamine in the human gastrointestinal tract. J Clin Endocrinol Metab 1997, 82:3864-3871.
7. Gaudin C., Ruget G., Selz F., Cuche J.L. Free and conjugated catecholamines in digestive tissues of rats. Life Sci 1985, 37:1469-1474.
8. Hartman D.S., Civelli O. Dopamine receptor diversity: molecular and pharmacological perspectives. Prog Drug Res 1997, 48:173-194.
9. Tan S., Hermann B., Borrelli E. Dopaminergic mouse mutants: investigating the roles of the different dopamine receptor subtypes and the dopamine transporter. Int Rev Neurobiol 2003, 54:145-197.
10. Vaughan C.J., Aherne A.M., Lane E., Power O., Carey R.M., O'Connell D.P. Identification and regional distribution of the dopamine D(1A) receptor in the gastrointestinal tract. Am J Physiol Regul Integr Comp Physiol 2000, 279:R599-R609.
11. Lucchelli A., Boselli C., Chiari M.C., Grana E. Analysis of the relaxing effect of dopamine on the isolated rat jejunum. Arch Int Pharmacodyn Ther 1986, 279:234-247.
12. Li Z.S., Schmauss C., Cuenca A., Ratcliffe E., Gershon M.D. Physiological modulation of intestinal motility by enteric dopaminergic neurons and the D2 receptor: analysis of dopamine receptor expression, location, development, and function in wild-type and knock-out mice. J Neurosci 2006, 26:2798-2807.
13. Lucchelli A., Boselli C., Grana E. Dopamine-induced relaxation of the guinea-pig isolated jejunum is not mediated through dopamine receptors. Pharmacol Res 1990, 22:433-444.
14. Grivegnee A.R., Fontaine J., Reuse J. Effect of dopamine on dog distal colon in-vitro. J Pharm Pharmacol 1984, 36:454-457.
15. Willems J.L., Buylaert W.A., Lefebvre R.A., Bogaert M.G. Neuronal dopamine receptors on autonomic ganglia and sympathetic nerves and dopamine receptors in the gastrointestinal system. Pharmacol Rev 1985, 37:165-216.
16. Walker J.K., Gainetdinov R.R., Mangel A.W., Caron M.G., Shetzline M.A. Mice lacking the dopamine transporter display altered regulation of distal colonic motility. Am J Physiol Gastrointest Liver Physiol 2000, 279:G311-G318.
17. Akimoto Y., Horinouchi T., Tanaka Y., Koike K. The beta3-adrenoceptor-mediated relaxation induced by dopamine in guinea pig taenia caecum. J Smooth Muscle Res 2003, 39:39-45.
18. Anderson G., Noorian A.R., Taylor G., Anitha M., Bernhard D., Srinivasan S., et al. Loss of enteric dopaminergic neurons and associated changes in colon motility in an MPTP mouse model of Parkinson's disease. Exp Neurol 2007, 207:4-12.
19. Eaker E.Y., Bixler G.B., Dunn A.J., Moreshead W.V., Mathias J.R. Dopamine and norepinephrine in the gastrointestinal tract of mice and the effects of neurotoxins. J Pharmacol Exp Ther 1988, 244:438-442.
20. Hyttel J. SCH 23390-the first selective dopamine D-1 antagonist. Eur J Pharmacol 1983, 91:153-154.
21. Crocker A.D. A new view of the role of dopamine receptors in the regulation of muscle tone. Clin Exp Pharmacol Physiol 1995, 22:846-850.
22. Reddymasu S.C., Soykan I., McCallum R.W. Domperidone: review of pharmacology and clinical applications in gastroenterology. Am J Gastroenterol 2007, 102:2036-2045.
23. Tonini M., Cipollina L., Poluzzi E., Crema F., Corazza G.R., De Ponti F. Review article: clinical implications of enteric and central D2 receptor blockade by antidopaminergic gastrointestinal prokinetics. Aliment Pharmacol Ther 2004, 19:379-390.
24. Kobayashi M., Iaccarino C., Saiardi A., Heidt V., Bozzi Y., Picetti R., et al. Simultaneous absence of dopamine D1 and D2 receptor-mediated signaling is lethal in mice. Proc Natl Acad Sci USA 2004, 101:11465-11470.
25. Ozaki M., Miyamoto Y., Kishioka S., Masuda Y., Yamamoto H. The dopaminergic system modulates the endogenous opioid system in guinea-pig isolated ileal longitudinal muscle. Neuropharmacology 1995, 34:473-480.
26. Ozaki M., Masuda Y., Kishioka S., Yamamoto H. Actions of domperidone on the opioid system in isolated guinea-pig ileum: differences between dopamine antagonists on opioid system. Auton Autacoid Pharmacol 2003, 23:57-62.
27. Bourne J.A. SCH 23390: the first selective dopamine D1-like receptor antagonist. CNS Drug Rev 2001, 7:399-414.
28. Gonzalez A., Sarna S.K. Neural regulation of in vitro giant contractions in the rat colon. Am J Physiol Gastrointest Liver Physiol 2001, 281:G275-G282.
29. Fuxe K., Ferre S., Genedani S., Franco R., Agnati L.F. Adenosine receptor-dopamine receptor interactions in the basal ganglia and their relevance for brain function. Physiol Behav 2007, 92:210-217.
30. Zizzo M.G., Bonomo A., Belluardo N., Mule' F., Serio R. A1 receptors mediate adenosine inhibitory effects in mouse ileum via activation of potassium channels. Life Sci 2009, 84:772-778.
31. Skarsfeldt T., Larsen J.J. SCH 23390-a selective dopamine D-1 receptor antagonist with putative 5-HT1 receptor agonistic activity. Eur J Pharmacol 1988, 148:389-395.
32. Sanders K.M. Regulation of smooth muscle excitation and contraction. Neurogastroenterol Motil 2008, 20(Suppl. 1):39-53.
33. Kishi M., Takeuchi T., Suthamnatpong N., Ishii T., Nishio H., Hata F., et al. VIP- and PACAP-mediated nonadrenergic, noncholinergic inhibition in longitudinal muscle of rat distal colon: involvement of activation of charybdotoxin- and apamin-sensitive K+ channels. Br J Pharmacol 1996, 119:623-630.
34. Vanneste G., Robberecht P., Lefebvre R.A. Inhibitory pathways in the circular muscle of rat jejunum. Br J Pharmacol 2004, 143:107-118.
35. Hagen B.M., Bayguinov O., Sanders K.M. VIP and PACAP regulate localized Ca2+ transients via cAMP-dependent mechanism. Am J Physiol Cell Physiol 2006, 291:C375-C385.
36. Zizzo M.G., Mule F., Serio R. Mechanisms underlying hyperpolarization evoked by P2Y receptor activation in mouse distal colon. Eur J Pharmacol 2006, 544:174-180.